ALAD - Asociación Latinoamericana de Diabetes

Name

ALAD - Asociación Latinoamericana de Diabetes

Legal name

ALAD - Asociación Latinoamericana de Diabetes

Website

https://aladlatam.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Panama City

HQ country

Panama

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership fees: ALAD generates revenue through membership fees from healthcare professionals across Latin America. Members pay annual dues (2023-2025 membership period mentioned). Active members in good standing have voting rights and access to the ALAD intranet.
2. Event registration and educational programs: Revenue from international courses, congresses, and educational programs including the Master in Diabetes and Obesity (online degree with Universidad de Alcalá), international courses on diabetes and cardiometabolic diseases.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

ALAD is a non-profit international scientific civil organization that unites healthcare professionals in 20 Latin American countries interested in diabetology. It delivers professional membership services, evidence-based clinical practice guidelines, the peer-reviewed Revista ALAD scientific journal, accredited continuing education (including a Master's in Diabetes and Obesity with Universidad de Alcalá de Henares), and regional congresses and policy advocacy initiatives.

Product overview

ALAD - Asociación Latinoamericana de Diabetes is a non-profit international scientific civil organization that unites healthcare professionals in Latin American countries interested in diabetology. The organization operates as a professional medical association rather than a technology product company. Its core offerings include: the Revista ALAD (ALAD Journal), a peer-reviewed quarterly scientific publication; clinical practice guidelines including the ALAD Guidelines on Type 2 Diabetes Mellitus (2019 Edition) and Standards of Care resources; educational programs including the Master's in Diabetes and Obesity with the University of Alcalá de Henares, and international courses in partnership with Emory University; the Consenso Nutrición ALAD 2025 consensus document; and member services through the ALAD membership system and Intranet portal. The organization also organizes regional congresses and educational events across Latin America.

Differentiator

Problem solved

Functional benefit

Products and services

• Revista ALAD (ALAD Journal)

Quantifiable outcome

• Policy dialogue established in 19 countries for diabetes patient protection
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered major, flagship and core.

• Asociación Panameña de Endocrinología, Diabetes y Metabolismo (APEDIM)majorStrategic or Co-development Partner · 15 April 2026The ALAD 2026-2028 Board was sworn in at the APEDIM Congress in Panama City, Panama, demonstrating close collaboration with the Panamanian endocrine society.
• Hospital Evangélico Mackenzie de CuritibamajorStrategic or Co-development Partner · 1 January 2026ALAD participates in the International Academic Cooperation Program with Hospital Evangélico Mackenzie de Curitiba, which includes scientific collaboration and professional exchange activities.
• World Health Organization / Pan American Health Organization (WHO/PAHO)flagshipStrategic or Co-development Partner · 1 November 2023ALAD partners with WHO/PAHO for the Latin American Summit on Health Policies for Diabetes Patient Protection (Panama, Nov-Dec 2023). PAHO provides auspices and financing alongside World Bank, UN Fund, IDB, OAS, and pharmaceutical industry for policy dialogue initiatives.
• International Diabetes Federation (IDF) - SACA RegioncoreStrategic or Co-development Partner · 1 November 2023ALAD works with IDF SACA on diabetes research and policy. In June 2026, ALAD and IDF SACA issued a joint statement defending academic freedom and biomedical research following an incident at the ADA Scientific Meeting 2026.
• Universidad de Alcalá de HenarescoreStrategic or Co-development Partner · 1 July 2023ALAD partners with Universidad de Alcalá de Henares (Spain) for the online Master in Diabetes and Obesity, offering an officially issued degree. This academic partnership provides accredited continuing education for healthcare professionals across Latin America.
• Emory University / Emory Diabetes Training AcademycoreStrategic or Co-development Partner · 1 January 2023ALAD collaborates with Emory University (Atlanta) and Emory Diabetes Training Academy for international courses and congresses on diabetes and cardiometabolic diseases. Programs include the International Course on Diabetes and Cardiometabolic Diseases (Punta Cana 2023), technology courses (Bogotá 2023), and virtual education programs.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Others

• International Society for Pediatric and Adolescent Diabetes (ISPAD):

Regional players

• Pan American Health Organization (PAHO/WHO): ALAD's flagship institutional partner providing auspices and financing for the 19-country Patient Protection Summit; not a competitor but a strategic counterpart in setting regional diabetes policy and convening ministries — included because PAHO's regional health-policy role directly overlaps with ALAD's advocacy mission.

Broad incumbents

• American Diabetes Association (ADA): Largest and most established diabetes scientific association globally; publishes the leading Standards of Care referenced by ALAD and runs the major ADA Scientific Meeting. Broader geographic scope and resources, but directly comparable mission in guidelines, journals, and CME.
• Breakthrough T1D (formerly JDRF): Global type 1 diabetes research and advocacy organization; comparable mission in driving diabetes research funding, scientific content, and KOL engagement, but with a much larger donor-funded operating model and US-centric base.

Direct peers

• American Association of Clinical Endocrinology (AACE): US-based clinical endocrinology society whose International Clinic Award was given to ALAD leadership; directly comparable as a professional society publishing clinical guidance and running educational programs for endocrinology/diabetes specialists.
• International Diabetes Federation (IDF): Global umbrella organization for diabetes societies; ALAD explicitly collaborates with IDF on research, the Diabetes Atlas, and joint statements (e.g., June 2026 academic-freedom statement), making IDF the closest structural peer operating one level above ALAD.
• European Association for the Study of Diabetes (EASD): Regional scientific society for diabetes in Europe; structurally identical to ALAD in unifying country-level societies, publishing guidelines and journals, and hosting annual scientific congresses for healthcare professionals.
• Sociedade Brasileira de Diabetes (SBD): Brazilian national diabetes society — the largest individual LATAM member society within ALAD's regional structure. Directly comparable as a country-level professional/scientific society offering guidelines, congresses, and CME for diabetology professionals.
• Sociedad Argentina de Diabetes: Argentine national diabetes society and ALAD member society in the Sur region; directly comparable professional society model (membership, guidelines, congresses, committees) targeting diabetology specialists in a single LATAM country.
• Sociedad Española de Diabetes (SED): Spanish national diabetes society and academic partner of ALAD via Universidad de Alcalá; highly comparable professional society model serving a Spanish-speaking healthcare-professional audience with similar CME, journal, and congress offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCLNBQzqSmH9gDwp-6mhc4fQ
• Facebookfacebook.com/alad.oficial
• LinkedInlinkedin.com/company/alad-asociaci%C3%B3n-latinoamericana-de-diabetes
• Instagraminstagram.com/alad.oficial

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ALAD - Asociación Latinoamericana de Diabetes